About Alere
Alere is a company based in Waltham (United States) founded in 1991 by Ron Zwanziger was acquired by Abbott in February 2016. Alere has raised $616.22 million across 26 funding rounds from investors including Abbott, UBS and Merrill Lynch. The company has 7,011 employees as of December 31, 2022. Alere has completed 12 acquisitions, including Alere Wellbeing, Arriva Medical and Biosite. Alere offers products and services including i-STAT, Afinion 2, and Cholestech LDX Analyzer. Alere operates in a competitive market with competitors including Think Research, UpHill, Dawn Health, Pathway and CLEW Medical, among others.
- Headquarter Waltham, United States
- Employees 7011 as on 31 Dec, 2022
- Founders Ron Zwanziger
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alere Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$616.22 M (USD)
in 26 rounds
-
Latest Funding Round
$425 M (USD), Debt – Conventional
May 28, 2013
-
Investors
Abbott
& 13 more
-
Employee Count
7011
as on Dec 31, 2022
-
Investments & Acquisitions
Alere Wellbeing
& 11 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alere
Alere offers a comprehensive portfolio of products and services, including i-STAT, Afinion 2, and Cholestech LDX Analyzer.
Portable device for rapid blood and chemistry testing
Analyzer for near-patient biomarker and CRP testing
Tool for quick glucose and lipid testing in five minutes
Funding Insights of Alere
Alere has successfully raised a total of $616.22M across 26 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $425 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alere
Alere has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Abbott, UBS and Merrill Lynch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by private equity firm TA.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
US healthcare companies are invested in stage-agnostically by Cutlass Capital.
|
Locked | Locked | Locked |
Investor details for Alere
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alere
Alere has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Alere Wellbeing, Arriva Medical and Biosite.
Investment portfolio details for Alere
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Golf course access and clubhouse facilities are offered to players.
|
Locked | Locked | 2008 | Locked | |
|
Medical applications are developed for healthcare by MedApps.
|
Locked | Locked | 2006 | Locked | |
|
Personalized coaching is offered for employee healthy lifestyle behaviors.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Alere
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Alere
Detailed financials for Alere
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alere Comparisons
Peer comparison for Alere
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alere
Alere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Think Research, UpHill, Dawn Health, Pathway and CLEW Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Expert clinical content and tools are provided for clinicians.
|
|
| Locked | Locked | Locked |
Clinical decision-making tools are developed for healthcare providers.
|
|
| Locked | Locked | Locked |
Developer of software as a medical device and digital therapeutics
|
|
| Locked | Locked | Locked |
Professional education courses are delivered by Pathway's center in Morocco.
|
|
| Locked | Locked | Locked |
AI-powered virtual ICU platform is provided for healthcare providers.
|
Detailed competitors of Alere
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alere
Complete news archive for Alere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alere
Alere was founded in 1991 and raised its 1st funding round 9 years after it was founded.
Alere is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Alere is a funded company, having raised a total of $616.22M across 26 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Alere is 7,011.
Founded in 1991 and headquartered in Waltham, United States, Alere operates in the diagnostics sector. Small rapid diagnostic devices are developed for infectious diseases, with additional focus on cardiology, oncology, drugs of abuse, and womens health. Products and services include over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, serving various health management needs globally.
Alere's top competitors include Dawn Health, Think Research and Apollo Intelligence.
Alere offers i-STAT, Afinion 2, and Cholestech LDX Analyzer.
Alere has made 12 acquisitions, including Alere Wellbeing, Arriva Medical, and Biosite.
Alere has 14 investors. Key investors include Abbott, UBS, Merrill Lynch, Gates Foundation, and Flagship Pioneering.